No Data
No Data
BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating
BofA Securities analyst Jason Zemansky maintains $Kura Oncology(KURA.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 67.9% and a total average return of 31.3% over
Express News | Kura Oncology Inc : BofA Global Research Raises Price Objective to $35 From $33
Dynavax, Bloomin Brands, and Premier Are the Most Shorted Small-cap Stock in May - Hazeltree Report
Kura Oncology(KURA.US) Officer Sells US$57,916.24 in Common Stock
$Kura Oncology(KURA.US)$ Officer Bair Teresa Brophy sold 2,615 shares of common stock on May 20, 2024 at an average price of $22.1477 for a total value of $57,916.24.Source: Announcement What is state
Investor Enthusiasm Soars for Kura Oncology (NASDAQ:KURA)
Buy Rating Affirmed for Kura Oncology Amidst Promising Ziftomenib Trials and Strategic Advantages
No Data